Analystreport

Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) had its price target raised by analysts at SVB Leerink LLC from $4.00 to $5.00. They now have a "market perform" rating

Satsuma Pharmaceuticals, Inc. - Common stock  (STSA) 
Last satsuma pharmaceuticals, inc. - common stock earnings: 3/10 04:01 pm Check Earnings Report